Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Sanofi ADR (SNY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sanofi ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
49.14 +0.57    +1.17%
31/01 - Closed. Currency in USD ( Disclaimer )
After Hours
48.50
-0.64
-1.30%
22:39:29 - Real-time Data
  • Volume: 1,327,464
  • Bid/Ask: 48.50 / 50.00
  • Day's Range: 48.60 - 49.19
Type:  Equity
Market:  United States
Sanofi ADR 49.14 +0.57 +1.17%

SNY Balance Sheet

 
Assess the latest Sanofi ADR balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Current Assets - 28646 - 30653
Cash and Short Term Investments 6899 - - 10098
Cash - - - -
Cash & Equivalents - 6899 - 10098
Short Term Investments - - - -
Total Receivables, Net - 8406 - 9787
Accounts Receivables - Trade, Net - 7868 - 7568
Total Inventory - 9366 - 8715
Prepaid Expenses - - - 615
Other Current Assets, Total - 3975 - 1427
Total Assets - 121826 - 120242
Property/Plant/Equipment, Total - Net - 11642 - 11976
Property/Plant/Equipment, Total - Gross - - - 27555
Accumulated Depreciation, Total - - - -15579
Goodwill, Net - 50555 - 48056
Intangibles, Net - 21978 - 21407
Long Term Investments - 2650 - 2425
Note Receivable - Long Term - 538 - 2219
Other Long Term Assets, Total - 918 - 642
Other Assets, Total - 10372 - 5449
Total Current Liabilities - 22077 - 21295
Accounts Payable - 6558 - 6180
Payable/Accrued - - - -
Accrued Expenses - - - 2554
Notes Payable/Short Term Debt - 149 - 189
Current Port. of LT Debt/Capital Leases - 3145 - 3264
Other Current liabilities, Total - 12225 - 9108
Total Liabilities - 50522 - 51211
Total Long Term Debt - 17943 - 18962
Long Term Debt - 15942 - 17123
Capital Lease Obligations - 2001 - 1839
Deferred Income Tax - 1550 - 1617
Minority Interest - 353 - 350
Other Liabilities, Total - 8113 - 8425
Total Equity 71304 - - 68681
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 2531 - 2527
Additional Paid-In Capital - 555 - 532
Retained Earnings (Accumulated Deficit) - - - -
Treasury Stock - Common - -1169 - -939
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 71304 69387 - 66911
Total Liabilities & Shareholders' Equity - 121826 - 120242
Total Common Shares Outstanding 1252 - 1249.2 1252.54
Total Preferred Shares Outstanding - - - -
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Comments

Write your thoughts about Sanofi ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email